Treating the symptoms of osteoarthritis: Oral treatments

Australian Family Physician

Volumn 37, Issue 3, 2008, Pages 133-135

  McMahon, Katie ^a   Nelson, Mark ^a,b   Jones, Graeme ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DICLOFENAC; GLUCOSAMINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR; TRAMADOL;

HUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; GLUCOSAMINE; HUMANS; OSTEOARTHRITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRAMADOL;

EID: 42449146616     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Australian Bureau of Statistics. Musculoskeletal conditions in Australia: a snapshot, 2004-05.
2. Reginster JY. The prevalence and burden of arthritis. Rheumatology (Oxford) 2002;41(Suppl 1):3-6.
3. Drazen JM. COX-2 inhibitors: a lesson in unexpected problems. N Engl J Med 2005;352:1131-2.
4. Bresalier RS, Sandler R, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092-102.
5. Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071-80.
6. White WB, West CR, Borer JS, et al. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol 2007;99:91-8.
7. McGettigan P, Henry.D, Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006;296:1633-44.
8. Singh G, Fort JG, Goldstein JL, et al. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med 2006;119:255-66.
9. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8.
10. Cepeda M, Camargo F, Zea C, Valencia L. Tramadol for osteoarthritis. Cochrane Database Syst Rev 2006; Art. No.: CD005522 DOI:10.1002/ 14651858.CD005522.pub2.
11. Towheed T, Maxwell L, Anastassiades T, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005 Issue 2; Art. No.:CD002946 DOI: 10.1002/14651858.CD002946.pub2.
12. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808.
13. Herrero-Beaumont G, Del Carmen IJ, Trabado M, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 2007;56:555-67.